2.15

7.50% 0.15

After Hours: 2.09 -0.06 -2.79%

Syros Pharmaceuticals Inc (SYRS)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Syros Pharmaceuticals Inc stock is traded at $2.15, with a volume of 371.01K. It is up +7.50% in the last 24 hours and up +31.10% over the past month. Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Previous Close:

$2.00

Open:

24h Volume:

371.01K

Relative Volume:

1.29

Market Cap:

$58.67M

Revenue:

$9.94M

Net Income/Loss:

$-144.49M

P/E Ratio:

-0.3842

EPS:

-5.5956

Net Cash Flow:

$-103.90M

1W Performance:

+14.36%

1M Performance:

+31.10%

6M Performance:

-59.81%

1Y Performance:

-45.57%

1-Day Range:

$2.00

$2.30

1-Week Range:

$1.85

$2.30

52-Week Range:

$1.43

$8.17

Syros Pharmaceuticals Inc Stock (SYRS) Company Profile

Name

Syros Pharmaceuticals Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

617-744-1340

Address

35 CAMBRIDGE PARK DRIVE, CAMBRIDGE

Employee

Twitter

@syrospharma

Next Earnings Date

2024-07-31

Latest SEC Filings

SYRS's Discussions on Twitter

Syros Pharmaceuticals Inc Stock (SYRS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-04-20	Upgrade	H.C. Wainwright	Neutral → Buy
Sep-22-20	Initiated	Alliance Global Partners	Buy
Jan-17-20	Downgrade	Wedbush	Outperform → Neutral
Mar-08-19	Resumed	JMP Securities	Mkt Outperform
Feb-14-19	Resumed	Oppenheimer	Outperform
Nov-05-18	Upgrade	ROTH Capital	Neutral → Buy
Mar-13-18	Reiterated	Wedbush	Outperform
Oct-31-17	Resumed	Piper Jaffray	Overweight
Oct-23-17	Initiated	ROTH Capital	Neutral
Aug-10-17	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform

View All

Syros Pharmaceuticals Inc Stock (SYRS) Latest News

04:50 AM

Syros Pharmaceuticals' SWOT analysis: stock faces challenges amid clinical setbacks - Investing.com India

04:50 AM

Sep 24, 2024

575,000 Shares in Spyre Therapeutics, Inc. (NASDAQ:SYRE) Bought by Logos Global Management LP - Defense World

Sep 24, 2024

Ratios Uncovered: Breaking Down Spyre Therapeutics Inc. (SYRE)’s Trailing Twelve Months Metrics - The Dwinnex

Sep 24, 2024

Symphony Environmental Technologies (LON:SYM) Shares Down 13.8% - Defense World

Sep 24, 2024

Spyre Therapeutics Inc.’s results are impressive - US Post News

Sep 24, 2024

Farallon Capital Management LLC Buys Shares of 666,000 Spyre Therapeutics, Inc. (NASDAQ:SYRE) - MarketBeat

Sep 24, 2024

Sep 23, 2024

100,000 Shares in Spyre Therapeutics, Inc. (NASDAQ:SYRE) Purchased by Integral Health Asset Management LLC - Defense World

Sep 23, 2024

Spyre Therapeutics (NASDAQ:SYRE) Shares Gap Down to $30.17 - MarketBeat

Sep 23, 2024

Xilio Therapeutics Inc (XLO) rating initates by Chardan Capital Markets - Knox Daily

Sep 23, 2024

Itau Unibanco Holding S.A. Takes $435,000 Position in Ross Stores, Inc. (NASDAQ:ROST) - Defense World

Sep 23, 2024

Avoro Capital Advisors LLC Purchases Shares of 1,839,138 Spyre Therapeutics, Inc. (NASDAQ:SYRE) - Defense World

Sep 23, 2024

Canada Pension Plan Investment Board Acquires 509,700 Shares of Symbotic Inc. (NASDAQ:SYM) - Defense World

Sep 23, 2024

Sep 21, 2024

Symbotic (NASDAQ:SYM) Shares Up 2.1% - Defense World

Sep 21, 2024

Sep 20, 2024

Arm Joins the PHLX Semiconductor Sector Index℠ (SOX℠) - sharewise

Sep 20, 2024

Sep 19, 2024

The Principles of Low-Carbon Tectonics: As Lygos, Pyran accelerate, we look at the why, the where, and the when - Biofuels Digest

Sep 19, 2024

Symbotic (NASDAQ:SYM) Shares Gap Up to $22.41 - Defense World

Sep 19, 2024

Sep 18, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc.SYRS - Kilgore News Herald

Sep 18, 2024

Quarterly Metrics: Quick and Current Ratios for Symbotic Inc (SYM) - The Dwinnex

Sep 18, 2024

Wall Street analysts’ outlook for Symbotic Inc (SYM) - SETE News

Sep 18, 2024

Sep 17, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc.SYRS - PR Newswire

Sep 17, 2024

Understanding the Risks of Investing in Syros Pharmaceuticals Inc. (SYRS) - Knox Daily

Sep 17, 2024

Symbotic (NASDAQ:SYM) Shares Gap Up to $22.41 - MarketBeat

Sep 17, 2024

Siyata Mobile Inc (SYTA) expanding its growth trajectory ahead - SETE News

Sep 17, 2024

What is the investor’s view on Syros Pharmaceuticals Inc. (SYRS)? - US Post News

Sep 17, 2024

Sep 14, 2024

Syros Pharmaceuticals Chief Financial Officer Acquires 407% More Stock - Simply Wall St

Sep 14, 2024

Sep 13, 2024